Showing results (1851-1860 of 2,023) with videos related to

Sort By:
Pageof 203
NEJM Evidence|August 26, 2025
In-Hospital Mortality in Hemorrhagic Myocardial InfarctionKeyur P Vora, Ankur Kalra, Chirag D Shah, et al.
Blood Advances|July 24, 2020
High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphomaErin A Dean, Rahul S Mhaskar, Hong Lu, et al.
Trials|June 27, 2014
Effectiveness of the head CT choice decision aid in parents of children with minor head trauma: study protocol for a multicenter randomized trialErik P Hess, Kirk D Wyatt, Anupam B Kharbanda, et al.
JAMA Network Open|July 13, 2021
Cost Conversations About Anticoagulation Between Patients With Atrial Fibrillation and Their Clinicians: A Secondary Analysis of a Randomized Clinical TrialCelia C Kamath, Rachel Giblon, Marlene Kunneman, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2018
Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short TelomeresIulia Popescu, Hannah Mannem, Spencer A Winters, et al.
Journal of Medicinal Chemistry|December 22, 1999
Potent, orally active GPIIb/IIIa antagonists containing a nipecotic acid subunit. Structure-activity studies leading to the discovery of RWJ-53308W J Hoekstra, B E Maryanoff, B P Damiano, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 26, 2008
Safety of gadoversetamide in patients with acute and chronic myocardial infarctionS Huber, R Muthupillai, B Cheong, et al.
Journal of Thoracic Imaging|December 1, 2012
ACR appropriateness Criteria® radiographically detected solitary pulmonary noduleJeffrey P Kanne, Leif E Jensen, Tan-Lucien H Mohammed, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 11, 2023
Optimizing the Utility of Anorectal Manometry for Diagnosis and Therapy: A Roundtable Review and RecommendationsSatish S C Rao, Nitin K Ahuja, Adil E Bharucha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2026
TBCRC 048 (Olaparib Expanded) Expansion Cohorts: Phase II Study of Olaparib Monotherapy for Patients With Metastatic Breast Cancer With Germline Mutations in <i>PALB2</i> or Somatic Mutations in <i>BRCA1</i> or <i>BRCA2</i>Nadine M Tung, Mark E Robson, Tianyu Li, et al.
Pageof 203